Search research articles
Contact Us
Filters
Showing results (31-40 of 617) with videos related to
Page
of 62
Sort By:
Schizophrenia Bulletin
|
September 17, 2005
New approaches to measurement and treatment research to improve cognition in schizophrenia
Mark A Geyer, Robert Heinssen
Biological Psychiatry
|
August 28, 2010
Studies in genetically modified mice suggest novel mechanisms of mood regulation
Athina Markou, Mark A Geyer
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
December 4, 2003
Animal behavior models of the mechanisms underlying antipsychotic atypicality
Mark A Geyer, Bart Ellenbroek
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1992
Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist
C W Callaway, M A Geyer
Psychophysiology
|
January 1, 1982
Habituation of the Blink reflex in normals and schizophrenic patients
M A Geyer, D L Braff
Psychopharmacology
|
January 1, 1991
A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants
M P Paulus, M A Geyer
The Journal of Pharmacology and Experimental Therapeutics
|
November 14, 1997
Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist
V P Bakshi, M A Geyer
Neuroscience
|
July 7, 1999
Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats
V P Bakshi, M A Geyer
European Journal of Pharmacology
|
October 28, 1983
Similarities of the effects of apomorphine and 3-PPP on serotonin neurons
E H Lee, M A Geyer
Neuropharmacology
|
October 1, 1980
Persistent effects of chronic administration of LSD on intracellular serotonin content in rat midbrain
E H Lee, M A Geyer
Page
of 62
Search research articles
Search
Showing results (31-40 of 617) with videos related to
Sort By:
Page
of 62
Schizophrenia Bulletin
|
September 17, 2005
New approaches to measurement and treatment research to improve cognition in schizophrenia
Mark A Geyer, Robert Heinssen
Biological Psychiatry
|
August 28, 2010
Studies in genetically modified mice suggest novel mechanisms of mood regulation
Athina Markou, Mark A Geyer
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
December 4, 2003
Animal behavior models of the mechanisms underlying antipsychotic atypicality
Mark A Geyer, Bart Ellenbroek
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1992
Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist
C W Callaway, M A Geyer
Psychophysiology
|
January 1, 1982
Habituation of the Blink reflex in normals and schizophrenic patients
M A Geyer, D L Braff
Psychopharmacology
|
January 1, 1991
A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants
M P Paulus, M A Geyer
The Journal of Pharmacology and Experimental Therapeutics
|
November 14, 1997
Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist
V P Bakshi, M A Geyer
Neuroscience
|
July 7, 1999
Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats
V P Bakshi, M A Geyer
European Journal of Pharmacology
|
October 28, 1983
Similarities of the effects of apomorphine and 3-PPP on serotonin neurons
E H Lee, M A Geyer
Neuropharmacology
|
October 1, 1980
Persistent effects of chronic administration of LSD on intracellular serotonin content in rat midbrain
E H Lee, M A Geyer
Page
of 62